Extended Data Table 4 Adverse reactions by treatment arm in NLMT

From: The National Lung Matrix Trial of personalized therapy in lung cancer

  1. The table shows for each treatment arm, the number (and percentage) of patients with an adverse reaction reported at any grade (1–4), at grade 2 and above (2–4), at grade 3 and above (3–4) and at grade 4. For those patients with at least one adverse reaction reported, the table shows the median, interquartile range (IQR) and range for the number of adverse reactions per patient.
Back to article page